Edibles and Drug Tests: The Nightly Dose Problem Nobody Prints on the Tin

Here is the number this article exists to put in front of you. In controlled dosing research at Johns Hopkins, a single brownie containing 25mg of THC, two and a half dispensary gummies' worth, pushed average urinary metabolite concentrations to 335 nanograms per milliliter. The standard workplace screening cutoff is 50. One moderate edible, one sitting, nearly seven times the line. The 50mg dose group averaged 713.

The uncomfortable arithmetic follows directly: the nightly 5 to 10mg regimens that our own dosing coverage describes for sleep and pain make you, in the eyes of a urine screen, a chronic cannabis user, with everything that means for detection windows. Edibles are also, milligram for milligram, the worst consumption route to be tested on, for a reason that is pure liver chemistry. This page walks through the published pharmacokinetics, the actual federal cutoffs, and the three scenarios that cover most readers. One boundary up front: we report detection science here. We do not coach anyone through beating a screen, partly on principle and partly because, as the research below shows, most of what is sold for that purpose is fiction anyway.

Why do edibles produce more of the tested metabolite?

Because urine screens do not look for THC. They look for THC-COOH, the waste product your liver makes from THC, and swallowing sends the whole dose through the liver first. Smoked or vaporized THC enters the blood through the lungs and reaches the brain before the liver sees much of it. An edible takes the opposite route, absorbed through the gut and carried straight into first-pass metabolism, where the liver converts it to 11-hydroxy-THC (the potent metabolite behind the edible high) and onward to 11-nor-9-carboxy-THC, THC-COOH, the inactive leftover that testing targets.

The route difference shows up in the excretion data. Huestis's standard pharmacokinetics review documents the higher metabolite-to-THC ratios that oral dosing produces, and the Johns Hopkins group's controlled comparisons in infrequent users, oral and vaporized doses in the same subjects, found the oral route producing higher urinary cannabinoid concentrations at comparable doses. In plain terms: a milligram you swallow generates more of the molecule the test hunts for than a milligram you inhale. The edible high is the first-pass effect experienced from the inside; the edible drug-test problem is the same effect measured in a cup.

How long after an edible will a urine test stay positive?

Frequency decides it almost entirely, because THC-COOH stores in fat and leaks out slowly. The workplace-testing literature puts occasional use at roughly three days of detectability at the 50 ng/mL screen, moderate use (several times a week) at five to seven days, daily use at ten to fifteen, and chronic heavy use at thirty days or more. Those are ranges from pooled data, not promises, and edibles sit at the long end of each range for the first-pass reasons above.

The controlled single-dose numbers make the starting point concrete. In the Hopkins oral dosing study, healthy adults ate brownies at three dose levels, and their peak urinary THC-COOH averaged as follows against the federal cutoffs.

Small study, six participants per dose group, peaks arriving six to nine hours after eating. Hold the exact numbers loosely and the shape firmly: even the smallest standard edible dose cleared the screening cutoff at peak by a factor of two in people with no cannabis routine at all.

Three scenarios cover most readers. The one-time user, a 10mg gummy on a Saturday: peak within a day, below screening cutoffs within days, at the short end of the occasional-use range. The weekend user, one dose most weekends: still occasional territory, with the caveat that fat storage starts compounding when doses land closer together. The nightly patient, 5 to 10mg every evening for sleep: this is daily use, the ten-to-fifteen-day window as the floor, and at steady state the honest description is that you should expect to screen positive for as long as the regimen continues and for weeks after it stops. The subjective effects end at bedtime. The metabolite does not read the label on your intentions, and it is the metabolite being measured. Our effects-duration guide covers the eight-hour experience; this is the thirty-day residue of it.

Does it matter that the gummy was legal hemp?

Not to the test, and mostly not to the consequences. Delta-9 THC from a licensed dispensary, delta-9 THC from a hemp DTC brand, and delta-8's close analog all feed the same metabolic pathway and trip the same immunoassay. The federal urine program screens at 50 ng/mL and confirms by mass spectrometry at 15, per SAMHSA's guidelines, and the confirmation step identifies the THC metabolite without asking which statute the source plant satisfied. Transportation workers face the strictest version: under 49 CFR Part 40, a verified THC positive stands regardless of state legality or medical authorization. A prescription-shaped explanation exists for almost every other drug class in the panel; for cannabis, federally, it does not.

This matters for the site's readership more with the hemp ban approaching, because the buyers moving from mail-order hemp gummies into dispensary channels are not changing their testing exposure at all. Legality of purchase and detectability in urine are two systems that share a molecule and nothing else.

What about blood, saliva, and hair tests?

Shorter windows in fluids, longer in hair, all documented in the Huestis review and the workplace-testing literature. Blood THC after an edible peaks lower than after smoking and falls within hours to a day or two for occasional users, longer with chronic use. Oral fluid testing skews toward recent use, hours to a day or two, and is the weakest match for edibles since swallowed products leave less residue in the mouth than smoked ones. Hair assays claim roughly a ninety-day lookback and carry the most documented interpretation problems, including environmental contamination disputes. Urine remains the standard for employment testing, which is why the rest of this article lives there.

The detox industry would like a word, and should not get one

Search this article's topic and the results above us are largely detox brands citing no studies, selling emergency drinks and seven-day flush kits to frightened patients at $40 to $90 a bottle. The published literature on those products is thin because there is little to publish: nothing sold over the counter accelerates the release of THC-COOH from fat tissue on command. What dilution does accomplish, drinking enough water to thin the sample, is well documented in the workplace-testing literature, and so are the validity checks (creatinine, specific gravity) that labs run precisely because dilution is the oldest trick available. A dilute specimen is not a negative; it is a flagged specimen and, under many employer policies, a retest. We are not going to route readers into that machinery. The honest levers are dose, frequency, and time, and only the last one works retroactively.

What can a medical user actually conclude?

That the two clocks run at wildly different speeds, and only one of them is printed on the tin. The therapeutic effect of a nightly gummy is spent by morning; the testable evidence of it accumulates for weeks. A patient choosing edibles over smoking for entirely sound health reasons is choosing the route that maximizes the tested metabolite per milligram, which is the kind of tradeoff someone should get to make with the numbers in front of them. Now you have the numbers, and the papers they came from are linked below, which is more than the top of the search results will ever hand you.